Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 4 (of 4 Records)

Query Trace: Syndrome and CES2[original query]
A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression.
Current drug metabolism 2008 May 9 (4): 336-43.
Ribelles N, López-Siles J, Sánchez A, González E, Sánchez M J, Carabantes F, Sánchez-Rovira P, Márquez A, Dueñas R, Sevilla I, Alba
A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Apr 17 (7): 2006-13.
Caronia Daniela, Martin Miguel, Sastre Javier, de la Torre Julio, García-Sáenz José Angel, Alonso Maria R, Moreno Leticia T, Pita Guillermo, Díaz-Rubio Eduardo, Benítez Javier, González-Neira An
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer.
Pharmacological research 2017 Aug .
Lam Siu W, van der Noort Vincent, van der Straaten Tahar, Honkoop Aafke H, Peters Godefridus J, Guchelaar Henk-Jan, Boven Ep
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 1 159 114232.
de With Mirjam, van Doorn Leni, Maasland Demi C, Mulder Tessa A M, Oomen-de Hoop Esther, Mostert Bianca, Homs Marjolein Y V, El Bouazzaoui Samira, Mathijssen Ron H J, van Schaik Ron H N, Bins Sand
TOP